gene in individuals relapsing just after treatment method Using the BCL2 antagonist venetoclax. sixty six Resistance to these agents has been related to these mutations in about 70% of instances, although they are usually subclonal as well as their distinct position leading to resistance really should be proven.??? "????????????????????????????????